Cas:1253789-98-8 (2S)-3-[benzyl(methyl)amino]-2-(phenylmethoxycarbonylamino)propanoic acid manufacturer & supplier

Chemical Name:(2S)-3-[benzyl(methyl)amino]-2-(phenylmethoxycarbonylamino)propanoic acid

CAS.NO:1253789-98-8

Synonyms:(2S)-3-[benzyl(methyl)amino]-2-{[(benzyloxy)carbonyl]amino}propanoic acid;(S)-3-(Benzyl(methyl)amino)-2-(((benzyloxy)carbonyl)amino)propanoic acid;(S)-3-(BENZYL(METHYL)AMINO)-2-(BENZYLOXYCARBONYLAMINO)PROPAIC ACID

Molecular Formula:C₁₉H₂₂N₂O₄

Molecular Weight:342.38900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:82.36000

Exact Mass:342.15800

LogP:2.70240

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (2S)-3-[benzyl(methyl)amino]-2-{[(benzyloxy)carbonyl]amino}propanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-3-(BENZYL(METHYL)AMINO)-2-(BENZYLOXYCARBONYLAMINO)PROPAIC ACID physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2S)-3-[benzyl(methyl)amino]-2-{[(benzyloxy)carbonyl]amino}propanoic acid Use and application,(S)-3-(Benzyl(methyl)amino)-2-(((benzyloxy)carbonyl)amino)propanoic acid technical grade,usp/ep/jp grade.

Related News: At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. (2S)-3-[benzyl(methyl)amino]-2-(phenylmethoxycarbonylamino)propanoic acid manufacturer Hong Kong confirmed its 14th coronavirus case late Saturday. The patient, an 80-year-old man, had traveled for a few hours to mainland China in early January, and later spent several days on a cruise ship in Japan with more than 3,000 passengers and employees. (2S)-3-[benzyl(methyl)amino]-2-(phenylmethoxycarbonylamino)propanoic acid supplier China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%. (2S)-3-[benzyl(methyl)amino]-2-(phenylmethoxycarbonylamino)propanoic acid vendor China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%. (2S)-3-[benzyl(methyl)amino]-2-(phenylmethoxycarbonylamino)propanoic acid factory At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.